Related Experiment Video

Updated: Jun 9, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Myocardial ischemia in patients with dilated cardiomyopathy

Wei Fang1, Jian Zhang, Zuo-Xiang He

  • 1Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Nuclear Medicine Communications
|September 3, 2010
PubMed

Insights

Dilated cardiomyopathy (DCM) involves enlarged heart chambers. Assessing myocardial blood flow and ischemia is crucial, as anti-ischemic therapy may improve outcomes in DCM patients.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Dilated cardiomyopathy (DCM) is defined by enlarged ventricles and impaired systolic function.
  • Emerging evidence suggests coronary microcirculation is affected in cardiomyopathies.
  • Abnormalities in left ventricular myocardial perfusion, motion, and metabolism are common in DCM.

Purpose of the Study:

  • To highlight the potential role of myocardial ischemia in DCM development and prognosis.
  • To emphasize the importance of assessing myocardial blood flow and ischemia in DCM patients.
  • To explore the therapeutic potential of anti-ischemic strategies in DCM.

Main Methods:

  • Review of recent studies on coronary microcirculation in cardiomyopathies.
  • Analysis of data on left ventricular perfusion, wall motion, and metabolism in DCM.
  • Evaluation of the prognostic significance of myocardial ischemia in DCM.

Main Results:

  • Myocardial ischemia may significantly contribute to DCM pathogenesis.
  • Ischemia assessment holds prognostic value for DCM patients.
  • Abnormalities in myocardial perfusion and metabolism are frequently observed.

Conclusions:

  • Myocardial ischemia is a key factor in dilated cardiomyopathy.
  • Assessing myocardial blood flow and ischemia is essential for DCM management.
  • Anti-ischemic therapy offers a promising approach to improve cardiac function and clinical outcomes in DCM-related heart failure.

More Related Videos

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...